INVESTED: April Edition

Good morning!

This month’s Invested explores how global disruption, innovation, and long-term thinking are reshaping markets and society. We examine fertilizer inflation and commodity shocks tied to the Iran conflict, Canada’s evolving energy opportunity, and the cybersecurity risks of advanced AI. We also highlight why ambitious shared missions matter for mental health, plus thought-provoking reads on family business succession and the future of personalized medicine.

Happy Reading!

VIEWPOINT SPOTLIGHT

INSIGHTS FROM THE VIEWPOINT TEAM

THE FERTILIZER FRONT: HOW THE IRAN WAR IS REPRICING THE COMMODITY COMPLEX

Almost a month into the Iran conflict, de-escalation efforts have eased immediate tensions but no durable resolution has emerged. The article by CIO Scott Smith argues the bigger risk now is fertilizer and food inflation, as disrupted Gulf natural gas supplies are driving urea prices higher during planting season. Corn, canola, and wheat face pressure, while diversified commodity exposure may better capture these shocks.

INSIGHTS FROM THE VIEWPOINT FOUNDATION

EXPLORING PHILANTHROPIC TRENDS & IMPACTFUL INITIATIVES

WHY HUMANS NEED BIG MISSIONS: PURPOSE, HOPE, & COLLECTIVE MENTAL HEALTH

Artemis II highlights why societies need ambitious shared goals. Big missions can create hope, strengthen social bonds, and restore belief in collective progress during uncertain times. Unlike fear, which narrows thinking, hope supports resilience, innovation, and sustained action. This article from the Viewpoint Foundation argues philanthropy should pursue “social moonshots” that inspire possibility while tackling mental health and systemic challenges.

APRIL’S INVESTMENT PULSE

WHAT TODAY’S MODERN MARKET TRENDS REVEAL ABOUT INVESTOR THINKING

WHAT IS ANTHROPIC’S MYTHOS AI MODEL & WHY DOES IT HAVE THE FINANCIAL WORLD IN A PANIC?

This article from the Financial Post discusses how Anthropic’s new AI model, Mythos, has alarmed financial regulators because it can autonomously detect and exploit serious software vulnerabilities far faster than previous systems. Banks and governments in Canada, the U.S., and the U.K. are assessing cyber risks, fearing coordinated attacks across shared financial infrastructure. Anthropic has restricted access, using it only to strengthen defences.

MARKET OUTLOOK: INVESTORS TAKE LONGER VIEW ON ENERGY SECTOR SHIFT

This interview by BNN Bloomberg and David Szybunka discusses how Canada’s energy sector is increasingly viewed as a durable long-term investment, supported by decades of reserves, steady demand, and geopolitical realities. Investors are shifting from short-term oil trades toward risk-adjusted opportunities in royalties, services, and natural gas. While market shocks create uncertainty, tighter global supply and higher capital spending could strengthen the sector’s multi-year outlook.

PODCAST PICK

UNLOCKING INSIGHTS, ONE EPISODE AT A TIME

FAHEEM OSMAN – COMMODITY QIS: AN UNDER-APPRECIATED SOURCE OF SYSTEMATIC RETURNS?

This episode of Flirting with Models features Faheem Osman of Macquarie Group discussing commodity QIS as an overlooked source of systematic returns. He explains strategies such as curve carry, index congestion, and volatility selling, and why commodities have delivered strong risk-adjusted performance. The conversation also explores weekly options, 0DTE trading, and what changing derivatives markets could mean for future volatility premiums.

MORE TO EXPLORE

CURATED READS FOR THE INQUISITIVE

A GIANT SUCCESSION WAVE IS COMING FOR FAMILY BUSINESSES

Family businesses, which generate much of global GDP, face a massive succession wave as founders retire. While they often benefit from trust, resilience, and long-term thinking, many lack formal succession plans. This article from The Economist looks at how poor transitions, family conflict, and unwilling heirs threaten survival, and how increasingly, firms may turn to professional managers, public listings, private equity, or outright sales.

THIS MAY BE THE MOST IMPORTANT MEDICAL STORY OF THE DECADE

A breakthrough personalized CRISPR treatment saved a baby with a deadly rare genetic disorder, showing how gene editing and mRNA technology could transform care for millions with rare diseases and various cancers. The science now exists, but outdated regulatory, funding systems, and manufacturing threaten progress. This article from The New York Times argues that medicine must treat bespoke gene therapies as scalable “molecular surgery,” not one-off miracles.